The Q4 EPS miss may cause short-term selling pressure, but the raised FY2027 margin guidance and strong cash flow support the turnaround narrative. Traders should watch the earnings call for commentary on Q3 margin contraction and tariff headwinds, as these could create volatility. The affirmed 3-5% organic sales growth outlook provides a floor for revenue expectations.
Price Chart
Executive Summary
Estee Lauder reported fiscal Q4 2026 adjusted EPS of $0.39, a 17.4% miss vs. the $0.47 consensus, though revenue of $3.627B slightly beat estimates. Full-year results showed a return to sales growth (reported +5%, organic +3%) with significant operating margin expansion. The company affirmed its fiscal 2027 organic sales growth outlook of 3-5% and raised its adjusted operating margin guidance to 12.7-13.5%, signaling confidence in its turnaround despite near-term EPS disappointment.
Key Financial Metrics
Key Facts
- Fiscal Q4 2026 adjusted EPS of $0.39 missed consensus of $0.47 by 17.4%
- Fiscal Q4 reported net sales of $3.627B (+6% YoY) slightly above consensus of $3.59B
- Full-year fiscal 2026 reported net sales of $15.049B (+5% YoY), organic net sales +3%
- Full-year adjusted operating margin expanded 320 bps to 11.2%
- Fiscal 2027 outlook: organic net sales growth of 3-5%, adjusted operating margin raised to 12.7-13.5%
- Full-year free cash flow nearly doubled to $1.32B from $0.67B
- Quarterly dividend maintained at $0.35 per share
Financial Impact
Q4 EPS miss of ~$0.08 vs consensus, but full-year results and FY2027 guidance show strong operational turnaround with margin expansion and cash flow improvement
Risk Factors
- Q4 EPS miss of 17.4% vs consensus could trigger negative sentiment
- Tariff headwinds of ~$100M expected in fiscal 2026, mostly in H2
- Q3 fiscal 2027 expected to show ~50bps operating margin contraction
- Geopolitical risks from Middle East conflict and China consumer uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001001250-26-000038 |
| Document: el-20260819.htm | 0001001250-26-000038 |
| Document: 0001001250-26-000038-index-headers.html | 0001001250-26-000038 |
| Document: 0001001250-26-000038-index.html | 0001001250-26-000038 |
| Document: 0001001250-26-000038.txt | 0001001250-26-000038 |
| 8-K Data (Synthetic) | 0001001250-26-000038 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $96.25 $100.29 | ▲ +4.20% | ▲ +2.07% | $91.97 (−4.45%) |
Sep 9, 2026 23d ago | Court Ruling | $98.77 $95.60 | ▼ −3.21% | ▼ −2.55% | $91.97 (−6.88%) |
Aug 19, 2026 6w ago | 8-K | $98.01 $105.06 | ▲ +7.19% | ▲ +7.58% | $91.97 (−6.16%) |
Jul 17, 2026 11w ago | Institutional Cluster | $82.13 $79.92 | ▼ −2.69% | ▼ −2.00% | $91.97 (+11.98%) |
Mar 24, 2026 27w ago | 8-K | $71.16 $71.73 | ▲ +0.80% | ▲ +1.22% | $91.97 (+29.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access